Literature DB >> 11746232

Methyl CpG-binding proteins and transcriptional repression.

P A Wade1.   

Abstract

Since its discovery, methylation of DNA in mammalian cells has been correlated with transcriptional repression and with specialized chromatin structures. Recently, considerable progress has been reported in the identification of protein factors with a highly conserved DNA interaction surface, termed the methyl CpG-binding domain or MBD. A subset has been biochemically linked to histone deacetylases, suggesting a molecular mechanism for the functional properties of methylated DNA. Despite several obvious attractions, the connection between MBD proteins and histone deacetylases fails to explain all the existing data. In fact, the biochemistry and DNA-binding properties of most MBD family members have not been adequately described and considerable evidence exists for alternative mechanisms in the repression of methylated loci. Null mutations have been generated in mice for several MBD family members, the phenotypes of the mutant animals raise important questions regarding the functions of the MBD family. Here, I review the biochemistry, DNA-binding properties, and genetics of the MBD proteins that are linked to transcriptional repression, namely, MeCP2, MBD1, MBD2, and MBD3. Several models to account for the functional properties of methylated DNA are presented. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746232     DOI: 10.1002/bies.10008

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  101 in total

1.  Ten members of the Arabidopsis gene family encoding methyl-CpG-binding domain proteins are transcriptionally active and at least one, AtMBD11, is crucial for normal development.

Authors:  Anita Berg; Trine J Meza; Mirela Mahić; Tage Thorstensen; Kjetil Kristiansen; Reidunn B Aalen
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

2.  Effect of CpG methylation on RAG1/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage.

Authors:  Hiroshi Nakase; Yousuke Takahama; Yoshiko Akamatsu
Journal:  EMBO Rep       Date:  2003-08       Impact factor: 8.807

3.  The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1.

Authors:  Brian E Reese; Kurtis E Bachman; Stephen B Baylin; Michael R Rountree
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 4.  CHD chromatin remodelers and the transcription cycle.

Authors:  Magdalena Murawska; Alexander Brehm
Journal:  Transcription       Date:  2011-11-01

5.  Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription.

Authors:  Dong-Sheng Pei; Guo-Wei Qian; Hui Tian; Jie Mou; Wang Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-11-29

6.  DNA methylation and demethylation in Arabidopsis.

Authors:  Mary Gehring; Steven Henikoff
Journal:  Arabidopsis Book       Date:  2008-05-23

7.  DNA methylation: superior or subordinate in the epigenetic hierarchy?

Authors:  Bilian Jin; Yajun Li; Keith D Robertson
Journal:  Genes Cancer       Date:  2011-06

8.  Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-α gene in ovine uterine arteries via heightened promoter methylation.

Authors:  Chiranjib Dasgupta; Man Chen; Haitao Zhang; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

9.  Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.

Authors:  Laurie E Risner; Aravinda Kuntimaddi; Alyson A Lokken; Nicholas J Achille; Noah W Birch; Kelly Schoenfelt; John H Bushweller; Nancy J Zeleznik-Le
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 10.  Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance.

Authors:  Nagarjuna Vasagiri; Vijay Kumar Kutala
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.